The MAZ protein is an autoantigen of Hodgkin's disease and paraneoplastic cerebellar dysfunction

Annals of Neurology

Volumn 53, Issue 1, 2003, Pages 123-127

  Bataller, Luis ^a   Wade, Deborly F ^a   Graus, Francesc ^b   Rosenfeld, Myrna R ^a   Dalmau, Josep ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AUTOANTIGEN; BRAIN PROTEIN; DELETED IN COLORECTAL CANCER PROTEIN; EPITOPE; MYC ASSOCIATED ZINC FINGER PROTEIN; NETRIN; TR ANTIBODY; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ANTIGEN ANTIBODY REACTION; ARTICLE; AUTOIMMUNITY; CEREBELLUM DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; HODGKIN DISEASE; HUMAN; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PROTEIN INTERACTION; PURKINJE CELL;

EID: 0037233801     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10434     Document Type: Article

References (20)

1. Hammack J, Kotanides H, Rosenblum MK, Posner JB. Paraneoplastic cerebellar degeneration. II. Clinical and immunologic findings in 21 patients with Hodgkin's disease. Neurology 1992;42:1938-1943.
2. Graus F, Dalmau J, Valldeoriola F, et al. Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease. J Neuroimmunol 1997;74:55-61.
3. Graus F, Gultekin SH, Fetter I, et al. Localization of the neuronal antigen recognized by anti-Tr antibodies from patients with paraneoplastic cerebellar degeneration and Hodgkin's disease in the rat nervous system. Acta Neuropathol 1998;96:1-7.
4. Verschuuren JJ, Dalmau J, Tunkel R, et al. Antibodies against the calcium channel beta-subunit in Lambert-Eaton myasthenic syndrome. Neurology 1998;50:475-479.
5. Sodeyama N, Ishida K, Jaeckle KA, et al. Pattern of epitopic reactivity of the anti-Hu antibody on HuD with and without paraneoplastic syndrome. J Neurol Neurosurg Psychiatry 1999;66:97-99.
6. Nishikawa H, Tanida K, Ikeda H, et al. Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity. Proc Natl Acad Sci USA 2001;98:14571-14576.
7. Jager E, Chen YT, Drijfhout JW, et al. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med 1998;187:265-270.
8. Dalmau J, Gultekin SH, Voltz R, et al. Ma1, a novel neuronal and testis specific protein, is recognized by the serum of patients with paraneoplastic neurologic disorders. Brain 1999;122:27-39.
9. Furneaux HM, Rosenblum MK, Dalmau J, et al. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med 1990;322:1844-1851.
10. Ugai H, Li HO, Komatsu M, et al. Interaction of Myc-associated zinc finger protein with DCC, the product of a tumor-suppressor gene, during the neural differentiation of P19 EC cells. Biochem Biophys Res Commun 2001;286:1087-1097.
11. Bossone SA, Asselin C, Patel AJ, Marcu KB. MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination. Proc Natl Acad Sci USA 1992;89:7452-7456.
12. Komatsu M, Li HO, Tsutsui H, et al. MAZ, a Myc-associated zinc finger protein, is essential for the ME1a1-mediated expression of the c-myc gene during neuroectodermal differentiation of P19 cells. Oncogene 1997;15:1123-1131.
13. Williams LJ, Abou-Samra AB. The transcription factors SP1 and MAZ regulate expression of the parathyroid hormone/parathyroid hormone-related peptide receptor gene. J Mol Endocrinol 2000;25:309-319.
14. Llambi F, Causeret F, Bloch-Gallego E, Mehlen P. Netrin-1 acts as a survival factor via its receptors UNC5H and DCC. EMBO J 2001;20:2715-2722.
15. Sillevis SP, Kinoshita A, De Leeuw B, et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med 2000;342:21-27.
16. Bernal F, Shamsili S, Rojas I, et al. Clinical and immunological features of patients with anti-Tr antibodies. Neurology (in press).
17. Manley GT, Smitt PS, Dalmau J, Posner JB. Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites. Ann Neurol 1995;38:102-110.
18. Rosenfeld MR, Wong E, Dalmau J, et al. Cloning and characterization of a Lambert-Eaton myasthenic syndrome antigen. Ann Neurol 1993;33:113-120.
19. Leveque C, Hoshino T, David P, et al. The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen. Proc Natl Acad Sci USA 1992;89:3625-3629.
20. Takamori M, Iwasa K, Komai K. Antibodies to synthetic peptides of the α1A subunit of the voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome. Neurology 1997;48:1261-1265.